Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Treasury Shares: 2020-2024

Historic Treasury Shares for Eton Pharmaceuticals (ETON) over the last 4 years, with Dec 2024 value amounting to $226,068.

  • Eton Pharmaceuticals' Treasury Shares fell 17.55% to $226,068 in Q4 2024 from the same period last year, while for Dec 2024 it was $226,068, marking a year-over-year decrease of 17.55%. This contributed to the annual value of $226,068 for FY2024, which is 17.55% down from last year.
  • Eton Pharmaceuticals' Treasury Shares amounted to $226,068 in FY2024, which was down 17.55% from $274,204 recorded in FY2023.
  • In the past 5 years, Eton Pharmaceuticals' Treasury Shares ranged from a high of $369,606 in FY2022 and a low of $7,595 during FY2020.
  • Moreover, its 3-year median value for Treasury Shares was $274,204 (2023), whereas its average is $289,959.
  • Data for Eton Pharmaceuticals' Treasury Shares shows a maximum YoY fell of 25.81% (in 2023) over the last 5 years.
  • Yearly analysis of 4 years shows Eton Pharmaceuticals' Treasury Shares stood at $7,595 in 2020, then reached $369,606 in 2022, then dropped by 25.81% to $274,204 in 2023, then declined by 17.55% to $226,068 in 2024.